← All trials
NCT05850611
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2023
- Primary completion
- Aug 21, 2023
- Completion date
- Sep 21, 2024
- First posted
- May 9, 2023
- Last posted
- Oct 4, 2023
- Enrollment
- 20
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Mashhad University of Medical SciencesLead sponsor
- Mashhad University of Medical SciencesOverall official - principal investigator
- Mashhad University of Medical SciencesReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.